CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Case of Fulminant Type 1 Diabetes Mellitus after Recovery from COVID-19 Infection
Dong Woo Suh, Cha Gon Lee, Hong Kyu Lee, Jin Taek Kim
J Korean Diabetes. 2022;23(4):278-281.   Published online December 31, 2022
DOI: https://doi.org/10.4093/jkd.2022.23.4.278

Excel Download

A Case of Fulminant Type 1 Diabetes Mellitus after Recovery from COVID-19 Infection
The Journal of Korean Diabetes. 2022;23(4):278-281   Crossref logo
Link1 Link2 Link3

A case of fulminant type 1 diabetes mellitus after influenza B infection
Diabetes Research and Clinical Practice. 2008;79(3):e8-e9   Crossref logo
Link1 Link2

Delayed-onset Fulminant type 1 Diabetes Mellitus after the Discontinuation of Pembrolizumab Immunotherapy: A Case Report
. 2021;   Crossref logo
Link1 Link2

FULMINANT MYOCARDITIS AFTER RECOVERY FROM COVID-19 INFECTION: A CASE REPORT
Journal of the American College of Cardiology. 2022;79(9):2344   Crossref logo
Link1 Link2

Nivolumab
Reactions Weekly. 2017;1654(1):254-254   Crossref logo
Link1 Link2 Link3

Fulminant type 1 diabetes after COVID-19 vaccination
Diabetes & Metabolism. 2022;48(2):101324   Crossref logo
Link1 Link2

Durvalumab
Reactions Weekly. 2022;1929(1):269-269   Crossref logo
Link1 Link2 Link3

LBSUN292 Learning Lesson From A Case of Fulminant Type 1 Diabetes Mellitus Shortly After Pembrolizumab Treatment
Journal of the Endocrine Society. 2022;6(Supplement_1):A291-A291   Crossref logo
Link1 Link2

Case of fulminant type 1 diabetes mellitus associated with parvovirus B19 infection
Journal of Diabetes Investigation. 2014;5(4):472-473   Crossref logo
Link1 Link2 Link3

Nivolumab/tozinameran
Reactions Weekly. 2022;1909(1):434-434   Crossref logo
Link1 Link2 Link3